BioCatalyst

ABI-110 Low Dose, ABI-110 Medium Dose, ABI-110 High Dose — catalyst calendar

1 verified catalyst event(s) referencing ABI-110 Low Dose, ABI-110 Medium Dose, ABI-110 High Dose, each linked to its official source. Verified as of 2026-09-30.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-13
in 4mo
ESTIMATED
 READOUT
Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of
Phase 1/2 · Neovascular (Wet) AMD
 Avirmax Biopharma Inc ABI-110 Low Dose, ABI-110 Medium Dose, A ClinicalTrials.gov ↗
✓ Source-checked 2026-09-30
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.